+1 347 708 0418
This report studies the Meningococcal Vaccine market, covering market size for segment by type (Quadrivalent, Bivalent, etc.), by application (Pneumonia, Meningitis, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Novartis, GSK, Merck, CSL, Baxter, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed historical analysis of global market for Meningococcal Vaccine from 2016-2021, and provides extensive market forecasts from 2022-2030 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the Meningococcal Vaccine market.
Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.
This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Leading players of Meningococcal Vaccine including:
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Market split by Type, can be divided into:
Quadrivalent
Bivalent
Others
Market split by Application, can be divided into:
Pneumonia
Meningitis
Bacteremia
Others
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
Table of Contents
Chapter 1 Meningococcal Vaccine Market Overview
1.1 Meningococcal Vaccine Definition
1.2 Global Meningococcal Vaccine Market Size Status and Outlook (2016-2030)
1.3 Global Meningococcal Vaccine Market Size Comparison by Region (2016-2030)
1.4 Global Meningococcal Vaccine Market Size Comparison by Type (2016-2030)
1.5 Global Meningococcal Vaccine Market Size Comparison by Application (2016-2030)
1.6 Global Meningococcal Vaccine Market Size Comparison by Sales Channel (2016-2030)
1.7 Meningococcal Vaccine Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Post-Strategies of COVID-19
Chapter 2 Meningococcal Vaccine Market Segment Analysis by Player
2.1 Global Meningococcal Vaccine Sales and Market Share by Player (2019-2021)
2.2 Global Meningococcal Vaccine Revenue and Market Share by Player (2019-2021)
2.3 Global Meningococcal Vaccine Average Price by Player (2019-2021)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Meningococcal Vaccine Market Segment Analysis by Type
3.1 Global Meningococcal Vaccine Market by Type
3.1.1 Quadrivalent
3.1.2 Bivalent
3.1.3 Others
3.2 Global Meningococcal Vaccine Sales and Market Share by Type (2016-2021)
3.3 Global Meningococcal Vaccine Revenue and Market Share by Type (2016-2021)
3.4 Global Meningococcal Vaccine Average Price by Type (2016-2021)
3.5 Leading Players of Meningococcal Vaccine by Type in 2021
3.6 Conclusion of Segment by Type
Chapter 4 Meningococcal Vaccine Market Segment Analysis by Application
4.1 Global Meningococcal Vaccine Market by Application
4.1.1 Pneumonia
4.1.2 Meningitis
4.1.3 Bacteremia
4.1.4 Others
4.2 Global Meningococcal Vaccine Revenue and Market Share by Application (2016-2021)
4.3 Leading Consumers of Meningococcal Vaccine by Application in 2021
4.4 Conclusion of Segment by Application
Chapter 5 Meningococcal Vaccine Market Segment Analysis by Sales Channel
5.1 Global Meningococcal Vaccine Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global Meningococcal Vaccine Revenue and Market Share by Sales Channel (2016-2021)
5.3 Leading Distributors/Dealers of Meningococcal Vaccine by Sales Channel in 2021
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Meningococcal Vaccine Market Segment Analysis by Region
6.1 Global Meningococcal Vaccine Market Size and CAGR by Region (2016-2030)
6.2 Global Meningococcal Vaccine Sales and Market Share by Region (2016-2021)
6.3 Global Meningococcal Vaccine Revenue and Market Share by Region (2016-2021)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Meningococcal Vaccine Market Share by Type
6.4.3 North America Meningococcal Vaccine Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Meningococcal Vaccine Market Share by Type
6.5.3 Europe Meningococcal Vaccine Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Meningococcal Vaccine Market Share by Type
6.6.3 Asia-Pacific Meningococcal Vaccine Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Meningococcal Vaccine Market Share by Type
6.7.3 South America Meningococcal Vaccine Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Meningococcal Vaccine Market Share by Type
6.8.3 Middle East & Africa Meningococcal Vaccine Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Meningococcal Vaccine Players
7.1 Novartis
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 GSK
7.3 Merck
7.4 CSL
7.5 Baxter
7.6 JN International Medical Corporation
7.7 Serum Institute of India
7.8 Bio-Med
7.9 China National Biotec Group
7.10 Hualan Bio
7.11 Walvax
7.12 Zhifei
Chapter 8 Upstream and Downstream Analysis of Meningococcal Vaccine
8.1 Industrial Chain of Meningococcal Vaccine
8.2 Upstream of Meningococcal Vaccine
8.3 Downstream of Meningococcal Vaccine
Chapter 9 Development Trend of Meningococcal Vaccine (2022-2030)
9.1 Global Meningococcal Vaccine Market Size (Sales and Revenue) Forecast (2022-2030)
9.2 Global Meningococcal Vaccine Market Size and CAGR Forecast by Region (2022-2030)
9.3 Global Meningococcal Vaccine Market Size and CAGR Forecast by Type (2022-2030)
9.4 Global Meningococcal Vaccine Market Size and CAGR Forecast by Application (2022-2030)
9.5 Global Meningococcal Vaccine Market Size and CAGR Forecast by Sales Channel (2022-2030)
Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
List of Tables and Figures
Figure Meningococcal Vaccine Example
Figure Global Meningococcal Vaccine Revenue (Million $) Status and Outlook (2016-2030)
Figure Global Meningococcal Vaccine Revenue (Million $) Comparison by Region (2016-2030)
Figure Global Meningococcal Vaccine Revenue (Million $) Comparison by Type (2016-2030)
Figure Global Meningococcal Vaccine Revenue (Million $) Comparison by Application (2016-2030)
Figure Global Meningococcal Vaccine Revenue (Million $) Comparison by Sales Channel (2016-2030)
Table Global Meningococcal Vaccine Sales by Player (2019-2021)
Table Global Meningococcal Vaccine Sales Market Share by Player (2019-2021)
Figure Global Meningococcal Vaccine Sales Market Share by Player in 2021
Table Global Meningococcal Vaccine Revenue (Million $) by Player (2019-2021)
Table Global Meningococcal Vaccine Revenue Market Share by Player (2019-2021)
Figure Global Meningococcal Vaccine Revenue Market Share by Player in 2021
Table Global Meningococcal Vaccine Average Price by Player (2019-2021)
Figure Global Meningococcal Vaccine Average Price by Player in 2021
Figure Global Meningococcal Vaccine Players Competition Situation Top 5 Players Revenue Market Share in 2019
Figure Global Meningococcal Vaccine Players Competition Trends Top 5 Players Revenue Market Share in 2021
Figure Example of Quadrivalent
Figure Global Quadrivalent Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Bivalent
Figure Global Bivalent Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Others
Figure Global Others Revenue (Million $) and Growth Rate (2016-2021)
Table Global Meningococcal Vaccine Sales by Type (2016-2021)
Table Global Meningococcal Vaccine Sales Market Share by Type (2016-2021)
Figure Global Meningococcal Vaccine Sales Market Share by Type in 2021
Table Global Meningococcal Vaccine Revenue (Million $) by Type (2016-2021)
Table Global Meningococcal Vaccine Revenue Market Share by Type (2016-2021)
Figure Global Meningococcal Vaccine Revenue Market Share by Type in 2021
Table Global Meningococcal Vaccine Average Price by Type (2016-2021)
Figure Global Meningococcal Vaccine Average Price by Type in 2021
Table Leading Players of Meningococcal Vaccine by Type in 2021
Figure Example of Pneumonia
Figure Global Meningococcal Vaccine for Pneumonia Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Meningitis
Figure Global Meningococcal Vaccine for Meningitis Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Bacteremia
Figure Global Meningococcal Vaccine for Bacteremia Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Others
Figure Global Meningococcal Vaccine for Others Revenue (Million $) and Growth Rate (2016-2021)
Table Global Meningococcal Vaccine Sales by Application (2016-2021)
Table Global Meningococcal Vaccine Sales Market Share by Application (2016-2021)
Figure Global Meningococcal Vaccine Sales Market Share by Application in 2021
Table Leading Consumers of Meningococcal Vaccine by Application in 2021
Figure Example of Direct Channel
Figure Global Meningococcal Vaccine for Direct Channel Revenue (Million $) and Growth Rate (2016-2021)
Figure Example of Distribution Channel
Figure Global Meningococcal Vaccine for Distribution Channel Revenue (Million $) and Growth Rate (2016-2021)
Table Global Meningococcal Vaccine Revenue by Sales Channel (2016-2021)
Table Global Meningococcal Vaccine Revenue Market Share by Sales Channel (2016-2021)
Figure Global Meningococcal Vaccine Revenue Market Share by Sales Channel in 2021
Table Leading Distributors/Dealers of Meningococcal Vaccine by Sales Channel in 2021
Table Global Meningococcal Vaccine Market Size and CAGR by Region (2016-2030)
Table Global Meningococcal Vaccine Sales by Region (2016-2021)
Table Global Meningococcal Vaccine Sales Market Share by Region (2016-2021)
Figure Global Meningococcal Vaccine Sales Market Share by Region in 2021
Table Global Meningococcal Vaccine Revenue (Million $) by Region (2016-2021)
Table Global Meningococcal Vaccine Revenue Market Share by Region (2016-2021)
Figure Global Meningococcal Vaccine Revenue Market Share by Region in 2021
Table North America Meningococcal Vaccine Sales by Country (2016-2021)
Figure North America Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table North America Meningococcal Vaccine Revenue by Country (2016-2021)
Figure North America Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Figure North America Meningococcal Vaccine Market Share by Type in 2021
Figure North America Meningococcal Vaccine Market Share by Application in 2021
Figure United States Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure United States Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Canada Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Canada Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Mexico Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Mexico Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table Europe Meningococcal Vaccine Sales by Country (2016-2021)
Figure Europe Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table Europe Meningococcal Vaccine Revenue by Country (2016-2021)
Figure Europe Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Figure Europe Meningococcal Vaccine Market Share by Type in 2021
Figure Europe Meningococcal Vaccine Market Share by Application in 2021
Figure Germany Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Germany Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure UK Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure UK Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure France Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure France Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Italy Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Italy Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Russia Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Russia Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Spain Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Spain Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table Asia-Pacific Meningococcal Vaccine Sales by Country (2016-2021)
Figure Asia-Pacific Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table Asia-Pacific Meningococcal Vaccine Revenue by Country (2016-2021)
Figure Asia-Pacific Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Figure Asia-Pacific Meningococcal Vaccine Market Share by Type in 2021
Figure Asia-Pacific Meningococcal Vaccine Market Share by Application in 2021
Figure China Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure China Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Japan Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Japan Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Korea Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Korea Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure India Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure India Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Southeast Asia Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Australia Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Australia Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table South America Meningococcal Vaccine Sales by Country (2016-2021)
Figure South America Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table South America Meningococcal Vaccine Revenue by Country (2016-2021)
Figure South America Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Figure South America Meningococcal Vaccine Market Share by Type in 2021
Figure South America Meningococcal Vaccine Market Share by Application in 2021
Figure Brazil Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Brazil Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Argentina Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Argentina Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Colombia Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Colombia Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table Middle East & Africa Meningococcal Vaccine Sales by Country (2016-2021)
Figure Middle East & Africa Meningococcal Vaccine Sales Market Share by Country (2016-2021)
Table Middle East & Africa Meningococcal Vaccine Revenue by Country (2016-2021)
Figure Middle East & Africa Meningococcal Vaccine Revenue Market Share by Country (2016-2021)
Figure Middle East & Africa Meningococcal Vaccine Market Share by Type in 2021
Figure Middle East & Africa Meningococcal Vaccine Market Share by Application in 2021
Figure UAE Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure UAE Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure Saudi Arabia Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Figure South Africa Meningococcal Vaccine Sales and Growth Rate (2016-2021)
Figure South Africa Meningococcal Vaccine Revenue (Million $) and Growth Rate (2016-2021)
Table Company Snapshot of Novartis
Table Meningococcal Vaccine Introduction of Novartis
Table Meningococcal Vaccine Sales, Price, Revenue, Gross Margin and Market Share of Novartis (2019-2021)
Table Industrial Chain of Meningococcal Vaccine
Table Manufacturing Cost Structure of Meningococcal Vaccine
Table General Manufacturing Process of Meningococcal Vaccine
Table Leading Distributors/Dealers of Meningococcal Vaccine
Table Leading Consumers of Meningococcal Vaccine
Figure Global Meningococcal Vaccine Sales and Growth Rate Forecast (2022-2030)
Figure Global Meningococcal Vaccine Revenue and Growth Rate Forecast (2022-2030)
Table Global Meningococcal Vaccine Market Size and CAGR Forecast by Region (2022-2030)
Table Global Meningococcal Vaccine Market Size and CAGR Forecast by Type (2022-2030)
Table Global Meningococcal Vaccine Market Size and CAGR Forecast by Application (2022-2030)
Table Global Meningococcal Vaccine Market Size and CAGR Forecast by Sales Channel (2022-2030)
Buy
